Cannabis Processing
Search documents
Nextleaf Announces Launch of New Recreational Cannabis Brand
Newsfile· 2025-11-06 14:29
Vancouver, British Columbia--(Newsfile Corp. - November 6, 2025) - Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) ("Nextleaf", "OILS", or the "Company"), a multi-patented life science company and Canadian cannabis processor, is pleased to announce the national launch of its new recreational brand, Yard.Yard is designed for adult-use consumers seeking bold recreational cannabis experiences through high-potency extracts, premium hardware, and flavour-forward formulations. Developed at Nextlea ...
Nextleaf Provides Strategic Update: Canada's First 200-Pack Cannabis Softgels, and Opening of Distribution Facility
Newsfile· 2025-09-11 13:00
Core Insights - Nextleaf Solutions Ltd. has launched Canada's first 200-pack cannabis softgels under its brand Glacial Gold™, enhancing its market position and expansion capabilities [1][2][5] - The company has opened a new distribution facility to support its consumer-packaged goods portfolio [1][7] Product Launch - The 200-pack softgels are available in various formats, including RSO Full-Spectrum 5:5, high potency CBD 50, CBN:CBD 10:10, and CBG:THC 5:5 [4] - The introduction of this format aims to meet consumer demand for value and convenience, allowing for easier maintenance of wellness routines [5][6] Market Position - Glacial Gold is the top-selling brand for softgels in Western Canada and ranks among the top four brands in Ontario [5] - The new product format is expected to strengthen Glacial Gold's leadership in non-combustible, ingestible cannabis products [5] Distribution Facility - The new distribution facility spans 2,500 square feet and is located near the licensed processing site in Coquitlam, B.C. [7] - The facility will support expanded activities for the company's consumer-packaged goods [7] Company Overview - Nextleaf Solutions is an innovation-driven life science company and licensed cannabis processor with a portfolio of regulated consumer brands and high-potency bulk ingredients [10][11] - The company has a strong patent portfolio, including 19 U.S. patents and over 75 patents globally related to cannabinoid processing [11]
Nextleaf Reports Third Quarter FY25 Results Including Fourth Consecutive Profitable Quarter
Newsfile· 2025-08-28 13:00
Core Insights - Nextleaf Solutions Ltd. reported its financial results for Q3 FY2025, achieving gross revenue of $3,769,797, net revenue of $2,912,572, and gross profit of $1,107,593, marking the fourth consecutive profitable quarter without normalization [1][6]. Financial Performance - The gross profit increased by 25% from $884,344 in the same period last year, maintaining a steady gross margin of 29% [6]. - Year-to-date net income reached $867,352, a significant improvement of 172% from a loss of $1,196,316 in FY24 [6]. - Positive EBITDA of $1,112,285 year-to-date highlights the company's operational efficiency and disciplined cost management [6]. Market Position and Strategy - The company has streamlined its product portfolio and enhanced competitiveness through targeted SKU rationalization, strategic pricing, and brand innovation [2]. - Despite competitive pressure in saturated categories, Nextleaf remains on track to exceed FY24 revenue, net income, and adjusted EBITDA targets, driven by leadership in wellness-forward formats like softgels and oils [3]. Product Development and Launches - Nextleaf launched 11 new products under its flagship brand Glacial Gold, including 3 softgels, 5 vapes, and 3 bottled oils, with national distribution [4]. - The company focuses on delivering standardized, consistent, dose-controlled extracts with high potency and purity, appealing to wellness-focused adult-use consumers [4]. Financial Health - The company ended the quarter with no secured debt, a debt-to-equity ratio of 0.61, and strong shareholder equity of $5.6 million, indicating disciplined financial management [3][7]. - Working capital improved by 24% compared to year-end September 30, 2024, closing at $5,601,524 [7]. Future Outlook - The company plans to prioritize working capital allocation to strategic initiatives in Q4 FY2025, including scaling softgel innovation and advancing consumer value in vapes [9][13].